微創脊椎器材產品線 - 發展階段、細分市場、地區和國家、監管途徑、主要參與者（2024 年版）

該報告提供了有關微創脊椎器械產品線的全面信息，包括處於不同開發階段的產品的比較分析以及正在進行的臨床試驗的數據。

目錄

第1章 目錄

第2章簡介

第3章 開發中產品

• 微創脊椎器材 - 管道產品：依開發階段劃分
• 微創脊椎器材 - 管道產品：按細分市場
• 微創脊椎器材 - 管道產品：依地區
• 微創脊椎器材 - 管道產品：依監管途徑
• 微創脊椎裝置 - 管道產品：依預計核准日期
• 微創脊椎裝置 - 正在進行的臨床試驗

第4章 微創脊椎器材－各公司在研產品

• 微創脊椎器材公司 - 管道產品：依開發階段劃分
• 微創脊椎器材 - 管道產品：依開發階段劃分

第5章 微創脊椎器材公司及產品概述

第6章 微創脊椎裝置 - 最新進展

• 2024 年 10 月 8 日：SpineGuard 獲得空心 PsiFGuard 的 510(K) 批准
• 2024 年 9 月 30 日：SpineGuard 獲得 FDA 批准商業發佈 PsiFGuard，這是一種專用於骶髂關節固定的新型智慧鑽孔設備
• 2024 年 7 月 10 日：Aurora Spine Corporation 出席Sixth Annual American Society of Pain & Neuroscience Conference
• 2024 年 7 月 4 日：SurGenTec 獲得Ion Facet Screw System的額外 510(K) 許可
• 2024 年 5 月 30 日：與關鍵意見領袖合作，成功培訓
• 2024 年 3 月 12 日：改良的 MAGEC X 系統用於早發性脊椎側彎治療，現已在英國上市
• 2024 年 2 月 15 日：SurGenTec 獲得Ion Facet Screw System的額外 510(K) 許可
• 2023 年 12 月 12 日：ZimVie 宣佈Vital Spinal Fixation System與Brainlab Spine & Trauma Navigation相容
• 2023 年 11 月 13 日：Aurora Spine 安排電話會議以更新投資者資訊並報告 2023 年第三季業績

第7章附錄

GlobalData's Medical Devices sector report, "Minimally Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Minimally Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Minimally Invasive Spinal Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Minimally Invasive Spinal Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Minimally Invasive Spinal Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Minimally Invasive Spinal Devices Overview

3 Products under Development

• 3.1 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• 3.2 Minimally Invasive Spinal Devices - Pipeline Products by Segment
• 3.3 Minimally Invasive Spinal Devices - Pipeline Products by Territory
• 3.4 Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• 3.5 Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• 3.6 Minimally Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimally Invasive Spinal Devices - Pipeline Products under Development by Companies

• 4.1 Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• 4.2 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimally Invasive Spinal Devices Companies and Product Overview

6 Minimally Invasive Spinal Devices- Recent Developments

• 6.1 Oct 08, 2024: SpineGuard Receives 510(K) Clearance For Cannulated PsiFGuard
• 6.2 Sep 30, 2024: SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion
• 6.3 Jul 10, 2024: Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
• 6.4 Jul 04, 2024: SurGenTec Receives An Additional 510(K) Clearance For Ion Facet Screw System
• 6.5 May 30, 2024: Partnership With Key Opinion Leaders and Successful Trainings
• 6.6 Mar 12, 2024: Modified MAGEC X System for Early Onset Scoliosis Treatment Can Now be used in the UK
• 6.7 Feb 15, 2024: SurGenTec Receives Additional 510(K) Clearance For Ion Facet Screw System
• 6.8 Dec 12, 2023: ZimVie Announces Compatibility Between its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation
• 6.9 Nov 13, 2023: Aurora Spine Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Segment
• Minimally Invasive Spinal Devices - Pipeline Products by Territory
• Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimally Invasive Spinal Devices - Ongoing Clinical Trials
• Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Segment
• Minimally Invasive Spinal Devices - Pipeline Products by Territory
• Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimally Invasive Spinal Devices - Ongoing Clinical Trials